The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy

<i>Background and Objectives</i>: Protease activated receptor-2 (PAR2) is elevated in a variety of cancers and has been promoted as a potential therapeutic target. However, the clinical and prognostic values of PAR2 in hepatocellular carcinoma (HCC) are poorly characterized. This study a...

Full description

Bibliographic Details
Main Authors: Ming-Chao Tsai, Chih-Che Lin, Ding-Wei Chen, Yueh-Wei Liu, Yi-Ju Wu, Yi-Hao Yen, Pao-Yuan Huang, Chih-Chien Yao, Ching-Hui Chuang, Chang-Chun Hsiao
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Medicina
Subjects:
AFP
Online Access:https://www.mdpi.com/1648-9144/57/6/574